Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Data suggest that IRAK4 activity regulates activation of IRF5 (show IRF5 ELISA Kits), TAK1 (show MAP3K7 ELISA Kits), and IKKB (show IKBKB ELISA Kits) in monocytes; IRAK4 activation of TAK1 (show MAP3K7 ELISA Kits)-IKKB (show IKBKB ELISA Kits)-IRF5 (show IRF5 ELISA Kits) axis leads to induction of cytokines and interferons following TLR7 (show TLR7 ELISA Kits)/TLR8 (show TLR8 ELISA Kits) stimulation. (IRAK4 = interleukin-1 receptor-associated kinase 4; IRF5 (show IRF5 ELISA Kits) = interferon regulatory factor-5 (show IRF5 ELISA Kits); TAK1 (show MAP3K7 ELISA Kits) = MAPK (show MAPK1 ELISA Kits) kinase kinase 7; IKKB (show IKBKB ELISA Kits) = I-kappa B kinase; TLR = toll (show TLR4 ELISA Kits)-like receptor)
AMPK (show PRKAA1 ELISA Kits) activation inhibited IL-1beta (show IL1B ELISA Kits)-stimulated CXCL10 (show CXCL10 ELISA Kits) secretion, associated with reduced interleukin-1 receptor associated kinase-4 (IRAK4) phosphorylation.
By CRISPR/Cas9-induced inactivation of TLR9 (show TLR9 ELISA Kits), MyD88 (show MYD88 ELISA Kits), IRAK4 and IRAK1 (show IRAK1 ELISA Kits) we confirm that BZLF1 repression is dependent on functional TLR9 (show TLR9 ELISA Kits) and MyD88 (show MYD88 ELISA Kits) signaling, and identify IRAK4 as an essential element for TLR9 (show TLR9 ELISA Kits)-induced repression of BZLF1 expression upon BCR (show BCR ELISA Kits) cross-linking
the polymorphisms in TLR-MyD88 (show MYD88 ELISA Kits)-NF-kappaB (show NFKB1 ELISA Kits) signaling pathway confer genetic susceptibility to Type 2 diabetes mellitus and diabetic nephropathy.
data show that in pericytes, MyD88 (show MYD88 ELISA Kits) and IRAK4 are key regulators of 2 major injury responses: inflammatory and fibrogenic.
Data suggest that, in monocytes and macrophages, the interleukin-1B- (IL1B (show IL1B ELISA Kits))-stimulated trans-autophosphorylation of IRAK4 is initiated by MYD88- (myeloid differentiation primary response gene 88 (show MYD88 ELISA Kits))-induced dimerization of IRAK4. In contrast, IRAK1 (interleukin-1 receptor-associated kinase 1 (show IRAK1 ELISA Kits)) is inactive in unstimulated monocytes/macrophages and is converted to an active protein kinase (show CDK7 ELISA Kits) in response to IL1B (show IL1B ELISA Kits).
IRAK4 - Gene involved in innate immunity that have been associated with Chronic Rhinosinusitis.
The estimated prevalence of IRAK4 gene polymorphism found in a Portuguese Caucasian population was 26.8 % (CI 95%) [20.1, 34.7 %]. A model to predict the inflammatory response in the maxillary sinus in the presence etiological factors of dental origin was constructed.
This is the first study to show an association between single nucleotide polymorphisms in IRAK1 (show IRAK1 ELISA Kits), IRAK4 and MyD88 (show MYD88 ELISA Kits), and the presence of severe invasive pneumococcal disease.
Src (show SRC ELISA Kits), Syk (show SYK ELISA Kits), IRAK1 (show IRAK1 ELISA Kits), and IRAK4 have roles in anti-inflammatory responses mediated by dietary flavonoid Kaempferol
IRAK4 kinase activity contributes to murine lupus and could represent a new therapeutic target.
Data demonstrate that IRAK-4 is essential for innate and adaptive immunity and necessary for efficient control of mycobacterial infections.
Suppression of IRAK1 (show IRAK1 ELISA Kits) or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding-Defective Mutant of ABIN1 (show TNIP1 ELISA Kits)
PMA treatment during a vulnerable period can alter brain development. IL-18 and IRAK-4 appear to be important for the development of PMA induced injury.
enforced expression of miR (show MLXIP ELISA Kits)-302b or IRAK4 siRNA silencing inhibits downstream NF-kappaB (show NFKB1 ELISA Kits) signalling and airway leukocyte infiltration, thereby alleviating lung injury and increasing survival in P. aeruginosa-infected mice.
Our results demonstrate that osteoclasts and FBGCs are reciprocally regulated and identify IRAK4 as a potential therapeutic target to inhibit stimulated osteoclastogenesis and rescue inhibited FBGC formation
Suggest FC-99 is a potential therapeutic molecule that alleviated experimental sepsis by directly inhibiting IRAK4 activation.
MiR (show MLXIP ELISA Kits)-93 inhibits IRAK4 expression by binding directly to the 3'-UTR (show UTS2R ELISA Kits) of IRAK4.
This gene encodes a kinase that activates NF-kappaB in both the Toll-like receptor (TLR) and T-cell receptor (TCR) signaling pathways. The protein is essential for most innate immune responses. Mutations in this gene result in IRAK4 deficiency and recurrent invasive pneumococcal disease. Multiple transcript variants encoding different isoforms have been found for this gene.
interleukin-1 receptor-associated kinase 4
, interleukin-1 receptor-associated kinase 4-like
, Interleukin-1 receptor-associated kinase 4
, renal carcinoma antigen NY-REN-64
, NY-REN-64 antigen
, interleukin-1 receptor associated kinase 4